Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Clindamycin 2% vaginal cream |
| BNF code | 0702020E0AAAAAA |
| Virtual Therapeutic Moiety | Clindamycin |
| Date identifier became valid | 26 May 2021 |
| Previous product identifier | 326283008 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | applicator |
| Unit dose unit of measure | applicator |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Clindamycin phosphate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372786004 |
| Strength value numerator | 20.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | gram |
| Ontology Drug Form & Route | |
| Form & Route | cream.vaginal |
| Dose Form | |
| Formulation | Vaginal cream |
| Drug Route | |
| Route | Vaginal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Dalacin 2% cream (Pfizer Ltd) | |
| Dalacin 2% cream (Sigma Pharmaceuticals Plc) | |
| Virtual Medicinal Product Packs | |
| Clindamycin 2% vaginal cream 40 gram | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.